Abstr act This position paper identifies a potential problem with the evolution of software controlled safety critical systems. It observes that the rapid growth of bureaucracy in society quickly spills over into rules for behaviour. Whether the need for the rules comes first or there is simple anticipation of the need for a rule by a bureaucrat is unclear in many cases. Many such rules lead to draconian restrictions and often make the existing situation worse due to the presence of unintended consequences as will be shown with a number of examples.
Over view
Complex systems often exhibit unintended behaviour as a result of wellintentioned change. Some examples follow under a number of general headings.
Division of Responsibility
Dividing safety amongst separate bodies is known to be problematic. China's response to the melamine scandal that sickened over 53,000 infants who drank toxic milk formula in 2007-2008 is a perfect example. As (Lelyveld 2008) points out, the World Health Organisation specifically criticised China's division of responsibility for the part it played in this sad incident. In particular, China has separate ministries for health, agriculture, and commerce, as well as the State Food and Drug Administration (SFDA), the State Administration of Industry and Commerce (SAIC), and the General Administration of Quality Supervision, Inspection and Quarantine (GAQSIQ). Poor communication amongst such a diverse set of agencies is inevitable. This has considerable relevance to the corresponding position for safety-related software development as will be discussed further below.
The Chinese government has responded in the classic bureaucratic tradition by drafting new laws intended to prevent this happening again. Regrettably the new law is decidedly underwhelming. First the draft law bans all substances even those known to be harmless unless they have been officially approved as additives. Second, the draft law only, 'asks the departments, especially those at the grassroots level, to improve communication, cooperate closely with each other and faithfully fulfill their legal responsibilities' However, this does nothing to solve one of the major problems, which is conflict of interest. As one commentator in this article noted about the departments intended to carry out these directives, ' They have an incentive to keep the local economy growing and vibrant. But on the other hand, at the ministry level, they're supposed to be taking care of food safety.'
In other words, it is a classic bureaucratic fix whereby a law is made which may well make things worse (it is impossible to say), whereas one of the real problems is completely ignored.
Naming Confusion
There is of course a related problem to confusion over responsibility with no clear division of authority, that of nomenclature. A perfect example of this occurs with the naming of drugs. Since Celebrex (generic name celecoxib) made its debut in January 1999, there have been 53 reports of errors due to name confusion (Eustice and Eustice 1999).
The confusion arises because there are two other similarly-named drugs, Cerebyx and Celexa, with very different application.
• Celebrex (celecoxib) is the new COX-2 selective inhibitor used for the treatment of arthritis.
• Cerebyx (fosphenytoin) is an intravenous drug used to treat epilepsy.
• Celexa (citalopram) is a medication used to treat depression and symptoms of fibromyalgia.
The similarity among the names has caused confusion and mistakes, but no serious injuries or fatalities at the time of reporting in the reference. In 10 of the 53 reported cases, the patient actually received the wrong drug. In 19 of the cases, the wrong drug was prescribed but the error was caught before the patient was dispensed the wrong drug. In the remaining 24 cases, doctors and pharmacists re-
